Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 revenue decline. The company secured up to $250 million in R&D funding from Royalty Pharma.

The 2011 remake of Halo: Combat Evolved was developed by Saber Interactive because, according to its CEO, he offered to do it ...

Garrett discusses the recent surge in gold prices, attributing it to factors such as China's shift from investing in US dollars to gold, the potential for the US to monetize its gold reserves, and the ...

A one-year subscription to ExpressVPN is on sale for $99.95 and includes an extra three months for free — 49% off for a ...

We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal ...

The ultimate accessories' sale is LIVE! Maxxesorize Myntra Sale is offering 40-80% off on the trendiest jewellery, bags, watches, wallets, belts and more.

Following this sale to a syndicate of investors, Royalty Pharma will no longer receive Development Funding Bond payments over the remainder of 2025 and beyond. BofA Securities, Inc. acted as placement ...

Following this sale to a syndicate of investors, Royalty Pharma will no longer receive Development Funding Bond payments over the remainder of 2025 and beyond. BofA Securities, Inc. acted as ...

San Juan Basin Royalty Trust (NYSE ... they get analysis on some companies that is not published on the free site. Interested? Sign up here for a free two-week trial. Analyst’s Disclosure ...